New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2013
08:47 EDTMVCMVC Capital announces sale of Summit Research Labs
MVC Capital announced the signing of a definitive agreement to sell one of its portfolio companies, Summit Research Labs, a specialty chemical company that manufactures and markets antiperspirant actives globally, to an affiliate of One Rock Capital Partners, subject to regulatory approvals and the satisfaction of other customary closing conditions, including an escrow. Assuming full realization of the closing conditions and escrow and the sale of SCSD, MVC Capital would receive gross proceeds from its equity investment of approximately $63M, that results in an estimated gross IRR of 31% since August 2006. The gross IRR includes all fees and distributions received from its equity position in Summit over the life of the investment. The transaction is expected to close prior to March 31, 2013. The company is expected to record an approximate gain of $47M from the sale of the portfolio company.
News For MVC From The Last 14 Days
Check below for free stories on MVC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 11, 2014
08:47 EDTMVCMVC Capital announces sale of Octagon Credit Investors
MVC Capital announced that it has sold its interest in Octagon Credit Investors. MVC sold its equity interest to Octagon as part of a put option negotiated in 2008. MVC initially provided debt and equity financing to support management buying majority control of Octagon from J.P. Morgan in May 2004. In 2011, MVC received payment in full for its initial debt investment, while continuing to hold its equity interest. As a result of the sale, MVC generated an 8.9X return on equity capital and an IRR of 39%1, including fees and cash distributions received from Octagon.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use